Compare studies and check their requirements with the research team.
This study was withdrawn in the United States. It is testing latuda for Bipolarity.
In BostonThis study is directly about Bipolarity.
This summary needs review. Please check the official study record and contact the research team for details.
In San FranciscoThis study is directly about Bipolarity.
This summary needs review. Please check the official study record and contact the research team for details.
In PittsburghThis study is directly about Bipolarity.
This summary needs review. Please check the official study record and contact the research team for details.
In ClevelandThis study is directly about Bipolarity.
This study is completed in the United States, in Croatia, and in Ukraine. It focuses on manic episodes in bipolarity type I.
Multiple locations, including Little RockThis study is directly about Bipolarity.
This summary needs review. Please check the official study record and contact the research team for details.
In InnsbruckThis study is directly about Bipolarity.
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is directly about Bipolarity.
This summary needs review. Please check the official study record and contact the research team for details.
In CharlestonThis study is directly about Bipolarity.
This study is looking at whether a digital support tool can help people with bipolarity. Participants take part in a digital support tool and complete follow-up assessments.
In PittsburghThis study is directly about Bipolarity.
This study is looking at care and outcomes for people with bipolarity. Taking part may give some people access to Shared-decision making process, but direct benefit is not guaranteed.
Multiple locations, including BéziersThis study is directly about Bipolarity.
This summary needs review. Please check the official study record and contact the research team for details.
In VenturaThis study is directly about Bipolarity.
This study is completed. It is testing Licarbazepine 750-2000 mg/d for manic episodes in bipolarity type I.
Location not clearly listedThis study is directly about Bipolarity.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.